Named on 2 rounds in the feed.
Rounds from 2025-04-08 to 2025-07-23
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$221M
across 2 rounds
CO-INVESTORS
21
named beside it
Named on 2 rounds in the feed.
Rounds from 2025-04-08 to 2025-07-23
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Avalyn Pharma Avalyn Pharma develops inhaled therapies targeting rare respiratory diseases, specifically pulmonary fibrosis and interstitial lung diseases, for patients and their care partners. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-07-23 | [ PART ] |
Merida Biosciences Merida Biosciences develops precision therapies for autoimmune-driven diseases targeting pathogenic drivers of antibody-driven diseases. | Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $121M | 2025-04-08 | [ PART ] |